October 2, 2024 - HEDIS 2025 (Measurement Year 2024) HEDIS reporting season is here
For example, we offer music therapy, mind/body therapies, dance and movement therapy, yoga, and touch therapy
Possible Side Effects The Tesamorelin + Ipamorelin blend is generally well-tolerated in preclinical and limited human research settings, with side effects most often reported as mild and transient
Both are growth hormone releasing peptides (GHRP)
Wegovy HD is for adults who have tolerated 2.4 mg for at least 4 weeks and still need more weight loss
Comparing allodynia risk across GLP-1 medications As the GLP-1 medication landscape continues to expand, understanding the relative allodynia risk across different agents becomes increasingly relevant